Emmett Steward, MD
Hospitalist · Charlotte, NCNPI 1821066960
Payments from drug & device makers
Across 577 payments — averaging $19.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$1K
- Novartis$1K
- Boehringer Ingelheim$986
- Pfizer$853
- AstraZeneca$791
- plus $5K from 26 others
What the payments were for
- Food & beverage$11,138100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 77 | $1,455 |
| Johnson & Johnson | 64 | $1,236 |
| Novartis | 52 | $1,194 |
| Boehringer Ingelheim | 40 | $986 |
| Pfizer | 55 | $853 |
| AstraZeneca(2 entities) | 46 | $791 |
| Gilead | 29 | $738 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 32 | $693 |
| Merck | 24 | $528 |
| Paratek Pharmaceuticals, Inc. | 22 | $375 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 20 | $357 |
| Boston Scientific | 19 | $321 |
| E.r. Squibb & Sons, L.L.C. | 20 | $311 |
| Electromed, Inc. | 17 | $228 |
| Melinta Therapeutics, LLC | 13 | $207 |
| Alnylam Pharmaceuticals Inc. | 9 | $195 |
| Philips North America LLC | 7 | $135 |
| Otsuka America Pharmaceutical, Inc. | 7 | $125 |
| Daiichi Sankyo Inc. | 4 | $69 |
| Sunovion Pharmaceuticals Inc. | 4 | $49 |
| Amgen | 2 | $38 |
| Novo Nordisk | 2 | $37 |
| Shire North American Group Inc | 2 | $30 |
| Scpharmaceuticals Inc. | 1 | $30 |
| Bioxcel Therapeutics, Inc. | 1 | $24 |
| Insmed, Inc. | 1 | $23 |
| CMP Pharma, Inc. | 2 | $23 |
| Abbott | 1 | $22 |
| Bayer | 1 | $21 |
| Medtronic | 1 | $21 |
| GSK | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$108
How this compares
$11,152 in reported general payments places this provider in the 95th percentile of 879 hospitalist providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 27 | $310 |
| Tamsulosin Hcl | 15 | $295 |
| Potassium Chloride | 25 | $273 |
| Oxycodone Hcl | 25 | $159 |
| Hydralazine Hcl | 13 | $120 |
| Amlodipine Besylate | 14 | $69 |
| Carvedilol | 14 | $49 |
| Pantoprazole Sodium | 11 | $42 |
| Losartan Potassium | 15 | $41 |
| Prednisone | 14 | $29 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Charlotte
- Jenna BrooksCharlotte$24K
- Javad MonzavifarCharlotte$12K
- Bikki GautamCharlotte$12K
- Jorge PaulinoCharlotte$12K
- Tabita MorrisCharlotte$11K
- Samyak ManandharCharlotte$11K
- David HendersonCharlotte$10K
- Amsalu BizunehCharlotte$9K
- Harsha AlluCharlotte$9K
- Jehana JamesCharlotte$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.